Why do nt scan

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: NT scan, or nuchal translucency scan, is a prenatal ultrasound test typically performed between 11 and 14 weeks of pregnancy to assess the risk of chromosomal abnormalities like Down syndrome. It measures the fluid-filled space at the back of the fetus's neck, with a normal measurement being less than 3.5 millimeters. The scan is often combined with blood tests to provide a more accurate risk assessment, with detection rates for Down syndrome reaching about 85-90% when used in combination. It was developed in the 1990s and has become a standard part of prenatal care in many countries.

Key Facts

NT scan is performed between 11 and 14 weeks of gestation
Normal nuchal translucency measurement is less than 3.5 millimeters
Detection rate for Down syndrome is 85-90% when combined with blood tests
The test was developed in the 1990s
It assesses risk for chromosomal abnormalities like Down syndrome, Edwards syndrome, and Patau syndrome

Overview

The nuchal translucency (NT) scan is a specialized prenatal ultrasound examination that has become a cornerstone of modern obstetric care since its development in the 1990s. This non-invasive screening test is designed to assess the risk of chromosomal abnormalities in developing fetuses, particularly focusing on conditions such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13). The procedure was pioneered by researchers including Professor Kypros Nicolaides at King's College Hospital in London, who first described the correlation between increased nuchal translucency and chromosomal abnormalities in 1992. By 1995, the Fetal Medicine Foundation had established standardized measurement protocols that have since been adopted worldwide. The scan is typically scheduled between 11 weeks 0 days and 13 weeks 6 days of pregnancy, with the optimal timing being around 12 weeks when the fetus measures 45-84 millimeters from crown to rump. This timing coincides with the first trimester when the nuchal translucency is most measurable and before it naturally resolves as pregnancy progresses. The test has revolutionized prenatal screening by providing early risk assessment without invasive procedures, though it's important to note it remains a screening tool rather than a diagnostic test.

How It Works

The NT scan operates through high-resolution ultrasound technology that allows sonographers to visualize and measure the translucent space at the back of the fetal neck. During the procedure, which typically takes 20-30 minutes, the sonographer uses a transabdominal ultrasound probe to obtain a precise sagittal view of the fetus. The key measurement involves the subcutaneous collection of fluid between the skin and the cervical spine in the nuchal region. The sonographer identifies the fetus in a neutral position, not hyperextended or flexed, and measures the maximum thickness of this fluid-filled space in millimeters using on-screen calipers. This measurement is technically challenging and requires specialized training and certification, as factors like fetal position, gestational age, and maternal characteristics must be carefully considered. The process follows strict quality control standards established by organizations like the Fetal Medicine Foundation, which certifies sonographers who demonstrate consistent measurement accuracy. The NT measurement is then combined with maternal age and biochemical markers from blood tests (PAPP-A and free β-hCG) in what's called the combined first trimester screening. This integrated approach uses sophisticated algorithms to calculate a personalized risk score for chromosomal abnormalities, significantly improving detection rates compared to using maternal age alone.

Why It Matters

The NT scan holds significant importance in prenatal care by providing expectant parents with crucial early information about fetal health while maintaining safety through its non-invasive nature. This screening allows for early detection of potential chromosomal abnormalities, giving families more time for decision-making, counseling, and preparation. When abnormal results are found, parents can opt for diagnostic testing like chorionic villus sampling (CVS) or amniocentesis for confirmation. The scan's impact extends beyond chromosomal screening, as increased nuchal translucency can also indicate other conditions including congenital heart defects (present in approximately 25% of cases with increased NT), genetic syndromes, and structural abnormalities. By identifying these risks early, healthcare providers can arrange for specialized fetal echocardiography and additional monitoring. The test has become particularly valuable in countries with advanced healthcare systems, where it's often offered as part of routine prenatal care. Its significance is underscored by its ability to detect approximately 85-90% of Down syndrome cases when combined with blood tests, compared to just 30% detection using maternal age alone. This improved detection has transformed prenatal screening protocols worldwide while maintaining a low false-positive rate of about 5%, helping to reduce unnecessary invasive procedures.